Est. 2001·3,000+ placements · six offices · four regions
Product Launchcurated sourcedetected 2026-05-28 · confidence 75%

ACRE: Product Launch

ACRE announced its 5-year anniversary milestone with $300M+ in sales volume and is redefining its real estate platform through AI and media integration

Source: PR Newswire - Financial Services

The leadership read

Product momentum tends to widen the sector product and commercial leadership bench strength.

Market context: Against a Talent Market Index of 98.6 (Neutral) (down 1.4 month-on-month), Americas is at easing (-2.6pts) on signal share.

ACRE: 1 signal in the last 90 days; 0.1% of MitchelLake's Americas signal flow.

MitchelLake in this thematic

More signals across Americas

Product Launch · Americas

Faire

Faire officially expanded its wholesale marketplace in April 2026 to serve non-resale business use cases (hotels, offices, service businesses), after a successful pilot attracting ~5,000 buyers. CRO Jennifer Burke led discovery that buyers were sourcing items for corporate use rather than retail resale.

Product Launch · Americas

Revlon

Revlon is betting big on fragrance as a central pillar of its post-bankruptcy comeback strategy, with new president Amber Garrison leading the initiative.

Product Launch · Americas

The Estée Lauder Companies Inc.

Estée Lauder Companies and Jo Malone London launched Scent Scanner, an AI-driven fragrance recommendation experience on Pinterest that translates visual preferences into personalized product recommendations, rolling out in US and France.

Product Launch · Americas

Dolby Laboratories

Dolby Laboratories and NBCUniversal announced the first commercial use of Dolby AC-4 codec for live sports, streaming all 104 FIFA World Cup 2026 matches in Dolby Vision and Dolby Atmos via Peacock's Telemundo Spanish-language coverage.

Product Launch · Americas

Sea

Singapore-based Sea is launching Migoo, an AI chatbot, in the US market as part of a significant expansion into AI capabilities.

Product Launch · Americas

UniQure

UniQure received FDA clearance to submit marketing application for AMT-130, an experimental gene therapy for Huntington's disease. Company plans to file for accelerated approval in Q3 2026, reversing prior FDA opposition.

Weekly briefing

Track companies like ACRE — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

Nearby in the record

Share: WhatsApp · X · Email